AI Signal Dashboard
Last updated: 04.01 14:34
Top Undervalued
+5.4¢
(No)
New Coronavirus Pandemic in 2026? AI analysis: • +5.4¢ undervalued • Live Prediction Market fair value & mispricing alerts.
Undervalued Options Insights:
While the market prices 'Yes' at approximately 8%, fundamental analysis indicates its fair value sho...
🔓 Unlock Mispricing Insights (Pro)
Real-time High Yield Opportunities
View MoreAll
Outcomes
Market
Price
AI Fair
Value
Value
Edge
YesNo
6.45¢
93.55¢
1¢
99¢
0¢
+5.4¢
⚠️ Risk Warning: Live data may lag! Prices can shift instantly due to news or low liquidity. Before trading, use AI Chat for [Live Recalculate], [Check Liquidity], [Trollbox Radar], or review [Fair Value Logic] to verify.
Rule Risk
There is a moderate ambiguity risk. The title specifies a 'New Coronavirus Pandemic,' but the rules explicitly exclude 'COVID-19 (SARS-CoV-2)'. The risk lies in how the WHO distinguishes between 'variants' and 'new strains'. If a powerful variant of SARS-CoV-2 emerges with a new name but is technically within the same lineage, or if it's declared an 'endemic' surge rather than a 'pandemic', disputes may arise. Furthermore, 'Pandemic' is a specific official designation by the WHO with a high threshold, and the WHO has historically been cautious in declaring it.
Hedging
MRNA
Gold
PFE
S&P 500
Crude Oil
If the WHO were to declare a new coronavirus pandemic, it would be an extreme Black Swan event. The impact on financial markets would mirror early 2020, causing panic selling in global equities (like the S&P 500) while significantly boosting vaccine and biotech stocks (e.g., Pfizer, Moderna). In commodities, crude oil prices would likely crash due to lockdown expectations, while Gold might rise as a safe haven. The correlation is extremely high, representing a textbook hedging scenario.
Divergence
The market-implied 8% probability of a pandemic diverges significantly from the consensus of mainstream scientists and public health experts. Currently, the WHO and global CDC agencies are primarily focused on monitoring highly pathogenic avian influenza (like H5N1), and even for flu, the likelihood of a pandemic this year is considered extremely low. For a 'novel coronavirus', the scientific community's assessed probability of a pandemic is near 0%. The market's 8% pricing is largely driven by retail emotional premium and biological misclassification (conflating all pandemic pathogens with COVID-19).